Role of CSF-1 in progression of epithelial ovarian cancer

Setsuko K Chambers1

  • 1Women's Cancers, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA. schambers@azcc.arizona.edu

Insights

Understanding the role of CSF-1/c-fms signaling in ovarian cancer progression is crucial for developing new treatments. This study details its involvement in invasiveness and metastasis, including regulatory mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Epithelial ovarian cancer (EOC) has a poor prognosis, necessitating novel therapeutic strategies.
  • Understanding molecular pathways driving EOC progression and metastasis is critical for targeted treatment development.

Purpose of the Study:

  • To review current evidence on the role of Colony-Stimulating Factor 1 (CSF-1)/FMS tyrosine kinase receptor (c-fms) signaling in ovarian cancer invasiveness and metastasis.
  • To elucidate the regulatory mechanisms of CSF-1/c-fms expression, including post-transcriptional regulators.

Main Methods:

  • Literature review of existing studies on CSF-1/c-fms signaling in ovarian cancer.
  • Analysis of molecular pathways involved in cancer progression and metastasis.
  • Identification of post-transcriptional regulators affecting CSF-1/c-fms expression.

Main Results:

  • CSF-1/c-fms signaling significantly contributes to ovarian cancer cell invasiveness.
  • This signaling pathway plays a key role in promoting ovarian cancer metastasis.
  • Specific post-transcriptional regulators have been identified that influence CSF-1/c-fms expression.

Conclusions:

  • CSF-1/c-fms signaling is a critical factor in ovarian cancer progression and metastasis.
  • Targeting the CSF-1/c-fms pathway holds therapeutic potential for ovarian cancer.
  • Further research into CSF-1/c-fms regulation may reveal new therapeutic targets.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...